The hydroxychloroquine saga may finally be coming to an end.
Earlier this week, the Food and Drug Administration pulled its emergency use authorization for the drug, heavily touted by President Trump as a bulwark against the coronavirus. A couple of days later, the World Health Organization stopped its trial of the medication's effect on COVID-19 patients. Now, the National Institutes of Health have joined the consensus, halting its own clinical trial late Friday evening. NIH apparently agreed with the other agencies that the drug is "very unlikely" to benefit patients who require hospitalization.
Per Politico, this could be the drug's "death knell," at least in a certain respect. It's been around for decades and is approved to treat malaria, arthritis, and lupus, and doctors could still use it "off label" to treat coronavirus patients, but the end of the two major studies signal that scientists will focus elsewhere in the hopes of finding a breakthrough treatment for severely ill patients. Gilead's antiviral remdesivir and a cheap steroid called dexamethasone are promising contenders. Read more at Politico.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Groypers: the alt-right group pulled into the foregroundThe Explainer The network is led by alt-right activist Nick Fuentes
-
10 concert tours to see this upcoming fallThe Week Recommends Concert tour season isn't over. Check out these headliners.
-
How to put student loan payments on pauseThe Explainer If you are starting to worry about missing payments, deferment and forbearance can help
-
Florida erases rainbow crosswalk at Pulse nightclubSpeed Read The colorful crosswalk was outside the former LGBTQ nightclub where 49 people were killed in a 2016 shooting
-
Trump says Smithsonian too focused on slavery's illsSpeed Read The president would prefer the museum to highlight 'success,' 'brightness' and 'the future'
-
Trump to host Kennedy Honors for Kiss, StalloneSpeed Read Actor Sylvester Stallone and the glam-rock band Kiss were among those named as this year's inductees
-
White House seeks to bend Smithsonian to Trump's viewSpeed Read The Smithsonian Institution's 21 museums are under review to ensure their content aligns with the president's interpretation of American history
-
Charlamagne Tha God irks Trump with Epstein talkSpeed Read The radio host said the Jeffrey Epstein scandal could help 'traditional conservatives' take back the Republican Party
-
CBS cancels Colbert's 'Late Show'Speed Read 'The Late Show with Stephen Colbert' is ending next year
-
Shakespeare not an absent spouse, study proposesspeed read A letter fragment suggests that the Shakespeares lived together all along, says scholar Matthew Steggle
-
New Mexico to investigate death of Gene Hackman, wifespeed read The Oscar-winning actor and his wife Betsy Arakawa were found dead in their home with no signs of foul play
